Somatic hypermutation of Ig genes is affected differently by failures in apoptosis caused by disruption of fas (lpr mutation) or by overexpression of Bcl-2

Scandinavian Journal of Immunology

Volumn 63, Issue 6, 2006, Pages 420-429

  Mastache, E F ^a,b   Lindroth, K ^b   Fernandez C ^b   Gonzalez Fernandez A ^a,b  

^a UNIVERSITY OF VIGO   (Spain)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; IMMUNOGLOBULIN; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BIOACCUMULATION; CONTROLLED STUDY; GENE DISRUPTION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC SELECTION; GERM CELL; INTRON; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOMATIC HYPERMUTATION; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; B-LYMPHOCYTE SUBSETS; GENE REARRANGEMENT, B-LYMPHOCYTE, LIGHT CHAIN; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, INBRED MRL LPR; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RECEPTORS, NEUROPEPTIDE; RECEPTORS, TUMOR NECROSIS FACTOR; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TRANSGENES;

EID: 33745570891     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.001758.x     Document Type: Article

References (43)

1. Opferman JT, Korsmeyer SJ. Apoptosis in the development and maintenance of the immune system. Nat Immun 2003;4:410-5.
2. Berek C, Berger A, Apel M. Maturation of the immune response in germinal centers. Cell 1991;67:1121-9.
3. Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996;381:751-8.
4. Kelsoe G. Life and death in germinal centers (redux). Immunity 1996;4:107-11.
5. Pulendran B, van Driel R, Nossal GJ. Immunological tolerance in germinal centres. Immunol Today 1997;18:27-32.
6. Papavasiliou F, Casellas R, Suh H et al. V(D)J recombination in mature B cells: a mechanism for altering antibody responses. Science 1997;278:298-301.
7. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999;15:269-90.
8. Green DR. Apoptotic pathways: paper wraps stone blunts scissors. Cell 2000;102:1-4.
9. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-56.
10. Krammer PH. CD95's deadly mission in the immune system. Nature 2000;407:789-95.
11. Smith KG, Nossal GJ, Tarlinton DM. FAS is highly expressed in the germinal center but is not required for regulation of the B-cell response to antigen. Proc Natl Acad Sci USA 1995;92:11628-32.
12. Martinez-Valdez H, Guret C, de Bouteiller O, Fugier I, Banchereau J, Liu YJ. Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2. J Exp Med 1996;183:971-7.
13. Liu YJ, Barthelemy C, de Bouteiller O, Arpin C, Durand I, Banchereau J. Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. Immunity 1995;2:239-48.
14. Choe J, Kim HS, Zhang X, Armitage RJ, Choi YS. Cellular and molecular factors that regulate the differentiation and apoptosis of germinal center B cells. Anti-Ig down-regulates Fas expression of CD40 ligand-stimulated germinal center B cells and inhibits Fas-mediated apoptosis. J Immunol 1996;157:1006-16.
15. Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, Rothstein TL, Weigert MG. The role of clonal selection and somatic mutation in autoimmunity. Nature 1987;328:805-11.
16. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-7.
17. Hande S, Notidis E, Manser T. Bcl-2 obstructs negative selection of autoreactive, hypermutated antibody V regions during memory B cell development. Immunity 1998;8:189-98.
18. Takahashi Y, Cerasoli DM, Dal Porto JM et al. Relaxed negative selection in germinal centers and impaired affinity maturation in bcl-xL transgenic mice. J Exp Med 1999;190:399-410.
19. van Eijk M, Defrance T, Hennino A, de Groot C. Death-receptor contribution to the germinal-center reaction. Trends Immunol 2001;22:677-82.
20. Smith KG, Weiss U, Rajewsky K, Nossal GJ, Tarlinton DM. Bcl-2 increases memory B cell recruitment but does not perturb selection in germinal centers. Immunity 1994;1:803-13.
21. Takahashi Y, Ohta H, Takemori T. Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire. Immunity 2001;14:181-92.
22. Kuo P, Alban A, Gebhard D, Diamond B. Overexpression of bcl-2 alters usage of mutational hot spots in germinal center B cells. Mol Immunol 1997;34:1011-8.
23. Smith KG, Light A, O'Reilly LA, Ang SM, Strasser A, Tarlinton D. bcl-2 transgene expression inhibits apoptosis in the germinal center and reveals differences in the selection of memory B cells and bone marrow antibody-forming cells. J Exp Med 2000;191:475-84.
24. González-Fernández Á, Milstein C. Analysis of somatic hypermutation in mouse Peyer's patches using immunoglobulin kappa light-chain transgenes. Proc Natl Acad Sci USA 1993;90:9862-6.
25. Jolly CJ, Klix N, Neuberger MS. Rapid methods for the analysis of immunoglobulin gene hypermutation: application to transgenic and gene targeted mice. Nucleic Acids Res 1997;25:1913-9.
26. Sharpe MJ, Milstein C, Jarvis JM, Neuberger MS. Somatic hypermutation of immunoglobulin kappa may depend on sequences 3′ of C kappa and occurs on passenger transgenes. EMBO J 1991;10:2139-45.
27. Betz AG, Rada C, Pannell R, Milstein C, Neuberger MS. Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: clustering, polarity, and specific hot spots. Proc Natl Acad Sci USA 1993;90:2385-8.
28. Strasser A, Harris AW, Vaux DL et al. Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr Top Microbiol Immunol 1990;166:175-81.
29. Singer GG, Abbas AK. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994;1:365-71.
30. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. New York: Cold Spring Harbor Laboratory Press, 1989.
31. Rada C, Gupta SK, Gherardi E, Milstein C. Mutation and selection during the secondary response to 2-phenyloxazolone. Proc Natl Acad Sci USA 1991;88:5508-12.
32. Neuberger MS. Novartis Medal Lecture. Antibodies: a paradigm for the evolution of molecular recognition. Biochem Soc Trans 2002;30:341-50.
33. Milstein C, Neuberger MS, Staden R. Both DNA strands of antibody genes are hypermutation targets. Proc Natl Acad Sci USA 1998;95:8791-4.
34. Betz AG, Milstein C, González-Fernández Á, Pannell R, Larson T, Neuberger MS. Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region. Cell 1994;77:239-48.
35. Wagner SD, Neuberger MS. Somatic hypermutation of immunoglobulin genes. Annu Rev Immunol 1996;14:441-57.
36. Rogozin IB, Pavlov YI, Bebenek K, Matsuda T, Kunkel TA. Somatic mutation hotspots correlate with DNA polymerase eta error spectrum. Nat Immun 2001;2:530-6.
37. Alabyev B, Manser T. Bcl-2 rescues the germinal center response but does not alter the V gene somatic hypermutation spectrum in MSH2-deficient mice. J Immunol 2002;169:3819-24.
38. Rada C, Ehrenstein MR, Neuberger MS, Milstein C. Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity 1998;9:135-41.
39. Reynaud CA, Aoufouchi S, Faili A, Weill JC. What role for AID: mutator, or assembler of the immunoglobulin mutasome? Nat Immun 2003;4:631-8.
40. Linette GP, Li Y, Roth K, Korsmeyer SJ. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc Natl Acad Sci USA 1996;93:9545-52.
41. Mazel S, Burtrum D, Petrie HT. Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J Exp Med 1996;183:2219-26.
42. O'Reilly LA, Huang DC, Strasser A. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J 1996;15:6979-90.
43. Huang DC, O'Reilly LA, Strasser A, Cory S. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J 1997;16:4628-38.